Live feed16:15:39·1551dSECFilingvia QuantisnowInterpace Biosciences, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.IDXG· Interpace Biosciences, Inc.Health CareOriginal source
